Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1

J Appl Physiol (1985). 2022 Nov 1;133(5):1055-1066. doi: 10.1152/japplphysiol.00035.2022. Epub 2022 Sep 15.

Abstract

AMP deaminase 1 (AMPD1; AMP → IMP + NH3) deficiency in skeletal muscle results in an inordinate accumulation of AMP during strenuous exercise, with some but not all studies reporting premature fatigue and reduced work capacity. To further explore these inconsistencies, we investigated the extent to which AMPD1 deficiency impacts skeletal muscle contractile function of different muscles and the [AMP]/AMPK responses to different intensities of fatiguing contractions. To reduce AMPD1 protein, we electroporated either an inhibitory AMPD1-specific miRNA encoding plasmid or a control plasmid, into contralateral EDL and SOL muscles of C57BL/6J mice (n = 48 males, 24 females). After 10 days, isolated muscles were assessed for isometric twitch, tetanic, and repeated fatiguing contraction characteristics using one of four (None, LOW, MOD, and HIGH) duty cycles. AMPD1 knockdown (∼35%) had no effect on twitch force or twitch contraction/relaxation kinetics. However, during maximal tetanic contractions, AMPD1 knockdown impaired both time-to-peak tension (TPT) and half-relaxation time (½ RT) in EDL, but not SOL muscle. In addition, AMPD1 knockdown in EDL exaggerated the AMP response to contractions at LOW (+100%) and MOD (+54%) duty cycles, but not at HIGH duty cycle. This accumulation of AMP was accompanied by increased AMPK phosphorylation (Thr-172; LOW +25%, MOD +34%) and downstream substrate phosphorylation (LOW +15%, MOD +17%). These responses to AMPD1 knockdown were not different between males and females. Our findings demonstrate that AMPD1 plays a role in maintaining skeletal muscle contractile function and regulating the energetic responses associated with repeated contractions in a muscle- but not sex-specific manner.NEW & NOTEWORTHY AMP deaminase 1 (AMPD1) deficiency has been associated with premature muscle fatigue and reduced work capacity, but this finding has been inconsistent. Herein, we report that although AMPD1 knockdown in mouse skeletal muscle does not change maximal isometric force, it negatively impacts muscle function by slowing contraction and relaxation kinetics in EDL muscle but not SOL muscle. Furthermore, AMPD1 knockdown differentially affects the [AMP]/AMPK responses to fatiguing contractions in an intensity-dependent manner in EDL muscle.

Keywords: sex differences; AMP deaminase; AMP-activated protein kinase; contraction; relaxation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP Deaminase* / genetics
  • AMP Deaminase* / metabolism
  • AMP Deaminase* / pharmacology
  • AMP-Activated Protein Kinases / metabolism
  • Adenine Nucleotides / metabolism
  • Adenine Nucleotides / pharmacology
  • Adenosine Monophosphate / metabolism
  • Adenosine Monophosphate / pharmacology
  • Animals
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs* / metabolism
  • Muscle Contraction / physiology
  • Muscle, Skeletal / physiology

Substances

  • Adenine Nucleotides
  • Adenosine Monophosphate
  • AMP Deaminase
  • AMP-Activated Protein Kinases
  • MicroRNAs

Supplementary concepts

  • Adenosine monophosphate deaminase deficiency

Associated data

  • figshare/10.6084/m9.figshare.18726560.v1
  • figshare/10.6084/m9.figshare.18726563.v1
  • figshare/10.6084/m9.figshare.18726551.v1
  • figshare/10.6084/m9.figshare.18726548.v1
  • figshare/10.6084/m9.figshare.18726554.v1
  • figshare/10.6084/m9.figshare.18726557.v1